The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 11, 2022

Filed:

Jul. 16, 2018
Applicant:

The Governing Council of the University of Toronto, Toronto, CA;

Inventors:

Eugenia Kumacheva, Toronto, CA;

Elisabeth Prince, Toronto, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12M 3/00 (2006.01); C12N 5/00 (2006.01); C12M 3/06 (2006.01); B01L 3/00 (2006.01); C12M 1/32 (2006.01); C12M 1/00 (2006.01); C12M 1/12 (2006.01); C12N 5/09 (2010.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C12M 23/16 (2013.01); B01L 3/5027 (2013.01); C12M 21/08 (2013.01); C12M 23/12 (2013.01); C12M 23/20 (2013.01); C12M 25/14 (2013.01); C12M 29/00 (2013.01); C12N 5/0693 (2013.01); G01N 33/5011 (2013.01); G01N 33/5032 (2013.01); B01L 2300/0809 (2013.01); B01L 2300/12 (2013.01); C12N 2533/30 (2013.01); C12N 2533/54 (2013.01); C12N 2533/56 (2013.01); C12N 2533/76 (2013.01); C12N 2533/78 (2013.01); C12N 2533/80 (2013.01);
Abstract

The present disclosure provides a method of producing uniformly sized organoids/multicellular spheroids using a microfluidic device having an array of microwells. The method involves several successive steps. First, a microfluidic device containing parallel rows of microwells that are connected with a supplying channel is filled with a wetting agent. The wetting agent is a liquid that is immiscible in water. For example, the wetting agent may be an organic liquid such as oil. In the next step, the agent in the supplying channel and the microwells is replaced with a suspension of cells in an aqueous solution that contains a precursor for a hydrogel. Next, the aqueous phase in the supplying channel is replaced with the agent, which leads to the formation of an array of droplets of cell suspension in the hydrogel precursor solution, which were compartmentalized in the wells. The droplets are then transformed into cell-laden hydrogels. Subsequently, the agent in the supplying channel is replaced with the cell culture medium continuously flowing through the microfluidic device and the cells within the hydrogels are transformed into multicellular spheroids.


Find Patent Forward Citations

Loading…